FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

20559011000001109: Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jun 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1526741000001110 Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ireland UC) 30 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1526751000001113 Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ireland UC) 30 tablet (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
1842971000001117 Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1842981000001115 Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
69323401000001111 Eviplera 200mg/25mg/245mg tablets (Gilead Sciences International Ltd) 30 tablet (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
69323501000001110 Eviplera 200mg/25mg/245mg tablets (Gilead Sciences International Ltd) 30 tablet en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Is a Generic Eviplera 200mg/25mg/245mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has AMP Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has specific active ingredient Tenofovir disoproxil fumarate true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has specific active ingredient Emtricitabine true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has specific active ingredient Rilpivirine hydrochloride false Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tenofovir disoproxil true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rilpivirine false Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has specific active ingredient Rilpivirine hydrochloride true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rilpivirine true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has basis of strength substance Tenofovir disoproxil true Inferred relationship Existential restriction modifier
Eviplera 200mg/25mg/245mg tablets (Gilead Sciences Ltd) 30 tablet Has basis of strength substance Rilpivirine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start